These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15763324)

  • 1. Second Forum on Liver Transplantation Liver transplantation for hepatitis C: how to control the virus?
    Clavien PA
    J Hepatol; 2005 Apr; 42(4):447. PubMed ID: 15763324
    [No Abstract]   [Full Text] [Related]  

  • 2. What determines the natural history of recurrent hepatitis C after liver transplantation?
    Berenguer M
    J Hepatol; 2005 Apr; 42(4):448-56. PubMed ID: 15763325
    [No Abstract]   [Full Text] [Related]  

  • 3. Second hepatitis C replication compartment indicated by viral dynamics during liver transplantation.
    Dahari H; Feliu A; Garcia-Retortillo M; Forns X; Neumann AU
    J Hepatol; 2005 Apr; 42(4):491-8. PubMed ID: 15763335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is retransplantation an option for recurrent hepatitis C cirrhosis after liver transplantation?
    Llado L; Castellote J; Figueras J
    J Hepatol; 2005 Apr; 42(4):468-72. PubMed ID: 15763328
    [No Abstract]   [Full Text] [Related]  

  • 5. How should we treat recurrent hepatitis C after liver transplantation?
    Morard I; Negro F
    J Hepatol; 2005 Apr; 42(4):462-8. PubMed ID: 15763327
    [No Abstract]   [Full Text] [Related]  

  • 6. Fibrosis progression after liver transplantation in patients with recurrent hepatitis C.
    Feray C
    J Hepatol; 2004 Nov; 41(5):862-3. PubMed ID: 15519662
    [No Abstract]   [Full Text] [Related]  

  • 7. The anhepatic phase of liver transplantation as a model for measuring the extra-hepatic replication of hepatitis C virus.
    Di Liberto G; Féray C
    J Hepatol; 2005 Apr; 42(4):441-3. PubMed ID: 15763322
    [No Abstract]   [Full Text] [Related]  

  • 8. Should we treat patients with chronic hepatitis C on the waiting list?
    Everson GT
    J Hepatol; 2005 Apr; 42(4):456-62. PubMed ID: 15763326
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecular and cellular aspects of hepatitis C virus reinfection after liver transplantation: how the early phase impacts on outcomes.
    McCaughan GW; Shackel NA; Bertolino P; Bowen DG
    Transplantation; 2009 Apr; 87(8):1105-11. PubMed ID: 19384153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of recurrent hepatitis C after liver transplantation].
    Ni LD; Chen CW
    Zhonghua Gan Zang Bing Za Zhi; 2005 Mar; 13(3):238-40. PubMed ID: 15760572
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of hepatitis C virus infection in the setting of liver transplantation.
    Rodriguez-Luna H; Vargas HE
    Liver Transpl; 2005 May; 11(5):479-89. PubMed ID: 15838917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapidly progressive recurrent hepatitis C virus infection starting 9 days after liver transplantation.
    Saraf N; Fiel MI; Deboccardo G; Emre S; Schiano TD
    Liver Transpl; 2007 Jun; 13(6):913-7. PubMed ID: 17539015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recurrence of hepatitis C virus (HCV) infection after liver transplantation for HCV-related disease: host factors and viral factors implicated in the occurrence and the severity of HCV recurrence].
    Schvoerer E; Thumann C; Soulier E; Royer C; Fafi-Kremer S; Brignon N; Ellero B; Woehl-Jaegle ML; Meyer C; Wolf P; Jaeck D; Stoll-Keller F
    Pathol Biol (Paris); 2006 Dec; 54(10):556-60. PubMed ID: 17027191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome after liver re-transplantation in patients with recurrent chronic hepatitis C.
    Bahra M; Neumann UP; Jacob D; Berg T; Neuhaus R; Langrehr JM; Neuhaus P
    Transpl Int; 2007 Sep; 20(9):771-8. PubMed ID: 17617179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus quasispecies: misunderstood and mistreated?
    McCaughan GW; Laskus T; Vargas HE
    Liver Transpl; 2003 Oct; 9(10):1048-52. PubMed ID: 14526399
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatitis C virus recurrence after liver transplantation: influence of immunosuppressive regimens on viral load and liver histology.
    Oton E; Barcena R; Castillo M; Barreales M; Blesa C; Moreno-Planas JM; Barrios C; Garrido A; Cuervas V
    Transplant Proc; 2006 Oct; 38(8):2499-501. PubMed ID: 17097980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes of living donor liver transplantation for hepatitis C virus (HCV)-positive patients.
    Takada Y; Haga H; Ito T; Nabeshima M; Ogawa K; Kasahara M; Oike F; Ueda M; Egawa H; Tanaka K
    Transplantation; 2006 Feb; 81(3):350-4. PubMed ID: 16477219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver transplantation for chronic hepatitis B and C: dilemmas and controversies.
    McDiarmid SV
    Liver Transpl; 2002 Oct; 8(10 Suppl 1):S1-2. PubMed ID: 12362290
    [No Abstract]   [Full Text] [Related]  

  • 19. [Recurrence of hepatitis C after liver transplantation].
    Salcedo Plaza M
    Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():86-93. PubMed ID: 11968352
    [No Abstract]   [Full Text] [Related]  

  • 20. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
    de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
    Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.